✦ LIBER ✦

247 Fulvestrant in the Treatment of Metastatic Breast Cancer (MBC). A Retrospective Analysis of the Results From Two Centers in Northern Greece

✍ Scribed by K. Papazisis; I. Boukovinas; D. Repana; E. Stergiou; L. Kontovinis; P. Papakotoulas; G. Kouvatseas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Austrian fulvestrant registry: resul

✍ Rupert Bartsch; Brigitte Mlineritsch; Michael Gnant; Thomas Niernberger; Ursula 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 236 KB

TaxolTM (Paclitaxel), epirubicin and cyc

✍ J.-M. Nabholtz; K. Khoo; J.R. Mackey; M. Smylie; T. Al-Tweigeri; D. Dudgeon; O. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB

489 Bevacizumab (BV) in combination with

✍ J. Glaspy; V. Dieras; A. Brufsky; D.W. Miles; S.C. Phan; J. O'Shaughnessy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

PCN35 A COST UTILITY ANALYSIS OF FULVEST

✍ M Pangali; A Christodoulopoulou; A Ardavanis; V Barbounis; E Galani; D Skarlos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

678 - Taxol™ (Paclitaxel), Epirubicin an

✍ J.-M. Nabholtz; K. Khoo; J.R. Mackey; M. Smylie; T Al-Tweigeri; D. Dubgeon; O. K 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 256 KB

PP-7-7 Taxol. (paclitaxel), epirubicin a

✍ J.-M. Nabholtz; K. Khoo; T. Al-Tweigeri; M. Smylie; D. Dudgeon; O. Keller; J. Fo 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 175 KB